Nanoparticle-based combinatorial therapy
AssigneeThe American University in Cairo
InventorsNancy Mohamed Elbaz, Wael Mamdouh Sayed Sayed Ahmed, Laila Ziko, Rania Siam
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe American University in Cairo
InventorsNancy Mohamed Elbaz, Wael Mamdouh Sayed Sayed Ahmed, Laila Ziko, Rania Siam
Estimating the term…
The present invention provides a nano-particle based structure or composition for a combinational cancer therapy. The structure has a doxorubicin (DOX) physically loaded on core-shell silver polymeric nanoparticles (AgN-Ps) with a ratio of 3.3-5.5% doxorubicin to 1% silver to 2-10% polymer. This structure enhances the cellular uptake of DOX in comparison to the current conventional combination therapy. The DOX-loaded nano-particles result in an improved the therapeutic efficiency of DOX, and reduced its toxicity, which cannot occur in case of adding DOX and AgNPs.
A nano-particle based composition for a combinational therapy for treatment of breast cancer comprising:
Dependencies are inferred from the claim text.